Promoter hypermethylation of tumor-related genes in the progression of colorectal neoplasia

International Journal of Cancer. Journal International Du Cancer
Alfa H C BaiWai K Leung

Abstract

Gene promoter hypermethylation is increasingly recognized to play an important role in cancer development through silencing of gene transcription. This study determined the methylation profiles of primary colorectal cancers and adenomas to elucidate the role of epigenetic changes in different stages of colorectal carcinogenesis. We examined the methylation profiles of 47 sporadic colorectal cancers, 36 colonic adenomas from patients without cancer and 34 colonic biopsies from patients without colonic lesions. Paired adjacent dysplasia tissues obtained from 17 cancer patients were also examined. Promoter hypermethylation in 10 tumor-related genes (APC, ATM, GSTP1, HLTF, MGMT, hMLH1, p14, p15, SOCS-1 and TIMP-3) were studied by methylation-specific PCR. Promoter hypermethylation was frequently detected in more than 40% of colonic cancers and adenomas in APC, ATM, HLTF, MGMT and hMLH1 genes (p < 0.0001 vs. normal). While low level of methylation was detected in p14, p15 and TIMP-3, there was no methylation detected in GSTP1 and SOCS-1. The frequencies of methylation were comparable between tumors and adenomas, and advanced and nonadvanced adenoma. In contrast, K-ras mutation was only detected in advanced adenomas and cancers. Conc...Continue Reading

References

Nov 22, 1994·Proceedings of the National Academy of Sciences of the United States of America·W H LeeW G Nelson
Apr 1, 1993·Gastroenterology·J BenhattarJ Costa
Sep 3, 1996·Proceedings of the National Academy of Sciences of the United States of America·J G HermanS B Baylin
Feb 13, 1999·Nature Genetics·P A Jones, P W Laird
Jul 21, 1999·Proceedings of the National Academy of Sciences of the United States of America·M ToyotaJ P Issa
Feb 10, 2000·The American Journal of Pathology·W K LeungA R Sepulveda
Sep 11, 2001·The American Journal of Pathology·A RashidS R Hamilton
Mar 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Helen R MoinovaSanford D Markowitz
Nov 26, 2002·International Journal of Cancer. Journal International Du Cancer·Ka-Fai ToJoseph J Y Sung
Feb 21, 2003·International Journal of Cancer. Journal International Du Cancer·Michael W Y ChanKa Fai To
Feb 25, 2003·The American Journal of Pathology·Seun-Ja ParkTsung-Teh Wu
Mar 26, 2003·The American Journal of Pathology·Carolyn BariolRobyn Ward

❮ Previous
Next ❯

Citations

Sep 18, 2007·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Marloes BerkhoutJudith W M Jeuken
Aug 19, 2007·Oncogene·L N KwongW F Dove
Jul 15, 2006·Gut·J J L WongR L Ward
Mar 29, 2012·Molecular Cancer·Sumit SandhuHao Ding
May 19, 2005·Arthritis Research & Therapy·Akihiko YoshimuraToshikatsu Hanada
Apr 30, 2010·Disease Models & Mechanisms·Melissa Conerly, William M Grady
Jun 27, 2008·Virchows Archiv : an International Journal of Pathology·Annegret MüllerUNKNOWN German HNPCC Consortium, German Cancer Aid Deutsche Krebshilfe
Sep 1, 2007·Expert Opinion on Medical Diagnostics·Ashley G Rivenbark, William B Coleman
May 25, 2013·Journal of Cellular Physiology·Chiara MolinariWainer Zoli
Oct 17, 2015·Cellular and Molecular Life Sciences : CMLS·Ludovic DhontAlexandra Belayew
Apr 22, 2008·International Journal of Cancer. Journal International Du Cancer·Andres RojasWilliam M Grady
Sep 25, 2009·Molecular Carcinogenesis·Scott C BorinsteinWilliam M Grady
Jan 1, 2012·Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznań and Polish Society of Radiation Oncology·Witold KyclerKatarzyna Lamperska
Sep 27, 2005·The American Journal of Gastroenterology·Wai K LeungJoseph J Y Sung
Mar 15, 2019·Molecular Human Reproduction·Tomoko HirakawaHisashi Narahara
Aug 11, 2017·Cancer Cell International·Jingwei LiuYuan Yuan
Aug 23, 2019·World Journal of Gastroenterology : WJG·Damian JacenikEric R Prossnitz
Jul 27, 2005·Biochemical Society Transactions·W M Grady
Nov 9, 2017·Molecular Medicine Reports·Erick Ayala-CalvilloLeticia González-Maya
Mar 1, 2019·Scientific Reports·Giovanni RandonFilippo Pietrantonio
Sep 24, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bo Bin LeeDuk-Hwan Kim
Jun 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yutaka SuehiroYuji Hinoda
May 19, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wai K LeungJoseph J Y Sung

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Related Papers

Laboratory Investigation; a Journal of Technical Methods and Pathology
Sun LeeGyeong Hoon Kang
Neoplasia : an International Journal for Oncology Research
Matthias P A EbertCatherine Lofton-Day
© 2021 Meta ULC. All rights reserved